4 completed. 3 Phase 3, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 3 |
| Phase 1 | 1 | Completed 1 |
Follow Lacosamide tablet: new trials by email Literature Review of Lacosamide tablet trials Research Report on Lacosamide tablet
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Lacosamide Versus Propranolol in Migraine Lacosamide tablet, Propranolol - Migraine Disorders | Phase 3 | Completed | Kafrelsheikh University | 600 | 2022-06-01 | 2024-05-01 |
| Safety and Efficacy of Lacosamide as Additional Therapy in Patients Suffering From Epileptic Tonic-Clonic Seizures Lacosamide Tablet, Lacosamide Oral Solution - Epilepsy | Phase 3 | Completed | UCB BIOSCIENCES, Inc. | 239 | 2015-08-03 | 2023-12-14 |
| A Study to Assess the Safety and Efficacy of Lacosamide Versus Placebo (a Pill Without Active Medication) in Patients With Idiopathic Generalised Epilepsy Who Are Already Taking Anti-epileptic Medications Lacosamide Tablet, Lasosamide Oral Solution, Placebo Tablet - Epilepsy | Phase 3 | Completed | UCB BIOSCIENCES, Inc. | 242 | 2015-04-01 | 2020-12-17 |
| Study to Evaluate the Pharmacokinetics, Safety, Tolerability of Single Dose Lacosamide in Subjects With Renal Impairment Compared to Healthy Subjects Lacosamide tablet - Healthy, Renal Impairment | Phase 1 | Completed | UCB BIOSCIENCES GmbH | 40 | 2004-06-01 | 2014-10-20 |
Epilepsy (2) · Epilepsy, Idiopathic Generalized (2) · Migraine Disorders (1) · Renal Insufficiency (1)
UCB BIOSCIENCES, Inc. (2) · Kafrelsheikh University (1) · UCB BIOSCIENCES GmbH (1)
Germany (3) · Australia (2) · Brazil (2) · Bulgaria (2) · China (2) · Czechia (2) · France (2) · Hungary (2) · Israel (2) · Italy (2) · Japan (2) · Mexico (2) · Poland (2) · Portugal (2) · Romania (2)
PMID 11914403, PMID 12807523, PMID 23737404, PMID 39460685, PMID 41863672